MedPath

Efficacy of Tadalafil on improvement of erectile dysfunctio

Phase 3
Recruiting
Conditions
Erectile dysfunction.
Male erectile dysfunction
Registration Number
IRCT20170807035551N2
Lead Sponsor
rology Research Center of Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Male
Target Recruitment
60
Inclusion Criteria

Erectile dysfunction after recovery from C0VID19
Men between the ages of 30 and 50
Obtaining patient consent

Exclusion Criteria

History of erectile dysfunction before COVID19
History of trauma or anatomical problems in the penis
A history of neurological disorders including spinal cord injury, stroke, and migraine
History of heart disease
History of taking mineral nitrate drugs

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Measuring the severity of erectile dysfunction. Timepoint: before intervention, two months after intervention. Method of measurement: International index of erectile function questionnaire.;Sexual satisfaction of patient. Timepoint: before intervention, two months after intervention. Method of measurement: International index of erectile function questionnaire.;Intensity of sexual desire. Timepoint: before intervention, two months after intervention. Method of measurement: International index of erectile function questionnaire.
Secondary Outcome Measures
NameTimeMethod
Complications of drug administration. Timepoint: During the intervention and two months after the start of the intervention. Method of measurement: Based on questions from the patient.
© Copyright 2025. All Rights Reserved by MedPath